Neil Gallagher - President, Head of R&D at Syndax Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Head of R&D
Issuer Symbol
SNDX on Nasdaq
All Insider Reports
All Insider Reports

Neil Gallagher - trading volume in the past year for Syndax Pharmaceuticals Inc

Holdings reported by Neil Gallagher for Syndax Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (Right to buy) 110,500 $1,618,825 $14.65 05 Feb 2025 Direct Common Stock
Common Stock 85,095 $1,319,313 $15.50 10 Feb 2025 Direct

Transactions reported by Neil Gallagher for Syndax Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.